000 01459 a2200421 4500
005 20250518023722.0
264 0 _c20191028
008 201910s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/s41375-019-0418-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBueno, Clara
245 0 0 _aCD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity.
_h[electronic resource]
260 _bLeukemia
_c08 2019
300 _a2090-2125 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAC133 Antigen
_ximmunology
650 0 4 _aAntigens, CD19
_ximmunology
650 0 4 _aGranulocyte Precursor Cells
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLeukemia, Biphenotypic, Acute
_ximmunology
650 0 4 _aReceptors, Chimeric Antigen
_ximmunology
700 1 _aVelasco-Hernandez, Talia
700 1 _aGutiérrez-Agüera, Francisco
700 1 _aZanetti, Samanta Romina
700 1 _aBaroni, Matteo L
700 1 _aSánchez-Martínez, Diego
700 1 _aMolina, Oscar
700 1 _aClosa, Adria
700 1 _aAgraz-Doblás, Antonio
700 1 _aMarín, Pedro
700 1 _aEyras, Eduardo
700 1 _aVarela, Ignacio
700 1 _aMenéndez, Pablo
773 0 _tLeukemia
_gvol. 33
_gno. 8
_gp. 2090-2125
856 4 0 _uhttps://doi.org/10.1038/s41375-019-0418-8
_zAvailable from publisher's website
999 _c29386389
_d29386389